Demographics of the study patients and controls
| Variable | Patients with TLE | Controls (n = 37) | ||||
|---|---|---|---|---|---|---|
| Refractory (n = 17) | Well controlled (n = 20) | |||||
| AED, anti-epileptic drug; CBZ, carbamazepine; OXC, oxcarbazepine. | ||||||
| Age (years, mean (SD)) | 32.1 (7.2) | 32.2 (6.6) | 32.2 (8.3) | |||
| Men/women | 4/13 | 9/11 | 13/24 | |||
| Duration of TLE (years, mean (SD)) | 22.7 (10.0) | 14.2 (10.1) | – | |||
| Seizure characteristics | ||||||
| Seizure free (no. of patients) | – | 11 | – | |||
| Seizure per month (mean (SD)) | 20.3 (38.2) | 0.03 (0.07) | – | |||
| Antiepileptic medication | ||||||
| Monotherapy | ||||||
| Carbamazepine | – | 10 | – | |||
| Oxcarbazepine | 4 | 7 | – | |||
| Phenytoin | – | 1 | – | |||
| Lamotrigine | – | 1 | – | |||
| Polytherapy | ||||||
| CBZ with other AED(s) | 7 | 1 | – | |||
| OXC with other AED(s) | 6 | – | – | |||